U.S. News & World Report has released its annual ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. Did your facility make the cut this year?

The change comes at a momentous time for the company's TAVR portfolio, which made history in May by receiving the very first FDA approval for treating asymptomatic severe AS.

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 

The FDA previously shared an early alert about this issue, but it was still reviewing the situation at the time. The new recall covers a total of more than 11,000 devices.

John Puskas, MD, chief of cardiothoracic surgery at Emory University Hospital Midtown, noted that both treatment options have their own benefits. It often depends on the patient's age and comorbidities, though there are other factors to consider as well. 

Prior studies have already evaluated how individual drinks affect the heart—but what about a person's beverage choices over an extended period of time?

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful. 

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.